Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Seema Thakore Meloni, Ph.D.

Title
Institution
Department
Address
Phone
Other Positions
Title
Institution
Department

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Ogbenna AA, Meloni S, Inzaule S, Hamers RL, Sigaloff K, Osibogun A, Adeyemo TA, Okonkwo P, Samuels JO, Kanki PJ, Rinke de Wit TF, Akanmu AS. The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation. PLoS One. 2020; 15(8):e0238027. PMID: 32841264.
    Citations:    
  2. Meloni ST, Agaba P, Chang CA, Yiltok E, Oguche S, Ejeliogu E, Agbaji O, Okonkwo P, Kanki PJ. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria. PLoS One. 2020; 15(7):e0236801. PMID: 32735566.
    Citations:    
  3. Onwuamah CK, Okpokwu J, Audu R, Imade G, Meloni ST, Okwuraiwe A, Chebu P, Musa AZ, Chaplin B, Dalhatu I, Agbaji O, Samuels J, Ezechi O, Ahmed M, Odaibo G, Olaleye DO, Okonkwo P, Salako BL, Raizes E, Yang C, Kanki PJ, Idigbe EO. Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study. BMC Microbiol. 2020 01 20; 20(1):17. PMID: 31959116.
    Citations:    
  4. Balogun M, Meloni ST, Igwilo UU, Roberts A, Okafor I, Sekoni A, Ogunsola F, Kanki PJ, Akanmu S. Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria. PLoS One. 2019; 14(7):e0219903. PMID: 31344057.
    Citations:    
  5. Meloni ST, Agbaji O, Chang CA, Agaba P, Imade G, Oguche S, Mukhtar A, Mitruka K, Cox MH, Zee A, Kanki P. The role of point-of-care viral load monitoring in achieving the target of 90% suppression in HIV-infected patients in Nigeria: study protocol for a randomized controlled trial. BMC Infect Dis. 2019 May 02; 19(1):368. PMID: 31046695.
    Citations:    
  6. Balogun MR, Sekoni AO, Meloni ST, Odukoya OO, Onajole AT, Longe-Peters OA, Ogunsola FT, Kanki PJ. Predictors of tuberculosis knowledge, attitudes and practices in urban slums in Nigeria: a cross-sectional study. Pan Afr Med J. 2019; 32:60. PMID: 31223352.
    Citations:    
  7. Agaba PA, Genberg BL, Sagay AS, Agbaji OO, Meloni ST, Dadem NY, Kolawole GO, Okonkwo P, Kanki PJ, Ware NC. Retention in Differentiated Care: Multiple Measures Analysis for a Decentralized HIV Care and Treatment Program in North Central Nigeria. J AIDS Clin Res. 2018; 9(2). PMID: 29682399.
    Citations:    
  8. Miles CH, Shpitser I, Kanki P, Meloni S, Tchetgen EJT. Quantifying an Adherence Path-Specific Effect of Antiretroviral Therapy in the Nigeria PEPFAR Program. J Am Stat Assoc. 2017; 112(520):1443-1452. PMID: 32042214.
    Citations:    
  9. Chaplin B, Imade G, Onwuamah C, Odaibo G, Audu R, Okpokwu J, Olaleye D, Meloni S, Rawizza H, Muazu M, Musa AZ, Samuel J, Agbaji O, Ezechi O, Idigbe E, Kanki PJ. Distinct Pattern of Thymidine Analogue Mutations with K65R in Patients Failing Tenofovir-Based Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2018 02; 34(2):228-233. PMID: 29084434.
    Citations:    Fields:    
  10. Meloni ST, Onwuamah CK, Agbaji O, Chaplin B, Olaleye DO, Audu R, Samuels J, Ezechi O, Imade G, Musa AZ, Odaibo G, Okpokwu J, Rawizza H, Mu'azu MA, Dalhatu I, Ahmed M, Okonkwo P, Raizes E, Ujah IAO, Yang C, Idigbe EO, Kanki PJ. Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options. Open Forum Infect Dis. 2017; 4(4):ofx233. PMID: 29255731.
    Citations:    
  11. Meloni ST, Chaplin B, Idoko J, Agbaji O, Akanmu S, Imade G, Okonkwo P, Murphy RL, Kanki PJ. Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program. AIDS Res Ther. 2017 Oct 13; 14(1):58. PMID: 29029637.
    Citations:    Fields:    Translation:HumansCells
  12. Agaba P, Meloni S, Sule H, Ocheke A, Agaba E, Idoko J, Kanki P. Factors associated with early menopause among women in Nigeria. J Virus Erad. 2017 Jul 01; 3(3):145-151. PMID: 28758022.
    Citations:    
  13. Agaba PA, Meloni ST, Sule HM, Ocheke AN, Agaba EI, Idoko JA, Kanki PJ. Prevalence and predictors of severe menopause symptoms among HIV-positive and -negative Nigerian women. Int J STD AIDS. 2017 11; 28(13):1325-1334. PMID: 28409538.
    Citations:    Fields:    Translation:Humans
  14. Agaba PA, Meloni ST, Sule HM, Agaba EI, Idoko JA, Kanki PJ. Sexual dysfunction and its determinants among women infected with HIV. Int J Gynaecol Obstet. 2017 Jun; 137(3):301-308. PMID: 28273350.
    Citations:    Fields:    Translation:Humans
  15. Agaba PA, Meloni ST, Sule HM, Agbaji OO, Sagay AS, Okonkwo P, Idoko JA, Kanki PJ. Treatment Outcomes Among Older Human Immunodeficiency Virus-Infected Adults in Nigeria. Open Forum Infect Dis. 2017; 4(2):ofx031. PMID: 29497627.
    Citations: 1     
  16. Meloni ST, Chang CA, Eisen G, Jolayemi T, Banigbe B, Okonkwo PI, Kanki PJ. Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria. PLoS One. 2016; 11(10):e0164030. PMID: 27764094.
    Citations: 6     Fields:    Translation:Humans
  17. Scarsi KK, Eisen G, Darin KM, Meloni ST, Rawizza HE, Tchetgen Tchetgen EJ, Agbaji OO, Onwujekwe DI, Gashau W, Nkado R, Okonkwo P, Murphy RL, Kanki PJ. Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort. Clin Infect Dis. 2016 Feb 15; 62(4):512-8. PMID: 26561532.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  18. Chang CA, Meloni ST, Eisen G, Chaplin B, Akande P, Okonkwo P, Rawizza HE, Tchetgen Tchetgen E, Kanki PJ. Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria. Open Forum Infect Dis. 2015 Dec; 2(4):ofv154. PMID: 26613097.
    Citations: 3     
  19. Hamel DJ, Sankalé JL, Samuels JO, Sarr AD, Chaplin B, Ofuche E, Meloni ST, Okonkwo P, Kanki PJ. Building laboratory capacity to support HIV care in Nigeria: Harvard/APIN PEPFAR, 2004-2012. Afr J Lab Med. 2015; 4(1). PMID: 26900573.
    Citations: 3     
  20. Sagay AS, Ebonyi AO, Meloni ST, Musa J, Oguche S, Ekwempu CC, Oyebode T, Ejeliogu E, Imade GE, Agbaji OO, Okonkwo P, Kanki PJ. Mother-to-Child Transmission Outcomes of HIV-Exposed Infants Followed Up in Jos North-Central Nigeria. Curr HIV Res. 2015; 13(3):193-200. PMID: 25986370.
    Citations: 4     Fields:    Translation:Humans
  21. Rawizza HE, Chang CA, Chaplin B, Ahmed IA, Meloni ST, Oyebode T, Banigbe B, Sagay AS, Adewole IF, Okonkwo P, Kanki PJ. Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria. Curr HIV Res. 2015; 13(3):201-9. PMID: 25986371.
    Citations: 5     Fields:    Translation:Humans
  22. Meloni ST, Chaplin B, Chang C, Rawizza H, Okonkwo P, Kanki PJ. Patterns of Adherence and Loss to Follow-Up in Pediatric Patients on ART in Nigeria. Curr HIV Res. 2015; 13(3):210-8. PMID: 25986372.
    Citations: 2     Fields:    Translation:Humans
  23. Ebonyi AO, Oguche S, Meloni ST, Sagay SA, Kyriacou DN, Achenbach CJ, Agbaji OO, Oyebode TA, Okonkwo P, Idoko JA, Kanki PJ. Predictors of Mortality in a Clinic Cohort of HIV-1 Infected Children Initiated on Antiretroviral Therapy in Jos, Nigeria. J AIDS Clin Res. 2014; 5(12). PMID: 30416842.
    Citations:    
  24. Balogun M, Sekoni A, Meloni ST, Odukoya O, Onajole A, Longe-Peters O, Ogunsola F, Kanki PJ. Trained community volunteers improve tuberculosis knowledge and attitudes among adults in a periurban community in southwest Nigeria. Am J Trop Med Hyg. 2015 Mar; 92(3):625-32. PMID: 25510722.
    Citations: 2     Fields:    Translation:Humans
  25. Chaplin B, Meloni S, Eisen G, Jolayemi T, Banigbe B, Adeola J, Wen C, Reyes Nieva H, Chang C, Okonkwo P, Kanki P. Scale-up of networked HIV treatment in Nigeria: creation of an integrated electronic medical records system. Int J Med Inform. 2015 Jan; 84(1):58-68. PMID: 25301692.
    Citations: 10     Fields:    Translation:HumansCells
  26. Meloni ST, Chang C, Chaplin B, Rawizza H, Jolayemi O, Banigbe B, Okonkwo P, Kanki P. Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria. Open Forum Infect Dis. 2014 Sep; 1(2):ofu055. PMID: 25734125.
    Citations: 15     
  27. Olaleye DO, Odaibo GN, Carney P, Agbaji O, Sagay AS, Muktar H, Akinyinka OO, Omigbodun AO, Ogunniyi A, Gashau W, Akanmu S, Ogunsola F, Chukwuka C, Okonkwo PI, Meloni ST, Adewole I, Kanki PJ, Murphy RL. Enhancement of health research capacity in Nigeria through north-south and in-country partnerships. Acad Med. 2014 Aug; 89(8 Suppl):S93-7. PMID: 25072590.
    Citations: 4     Fields:    Translation:Humans
  28. Imade GE, Sagay AS, Musa J, Ocheke AN, Adeniyi DS, Idighri M, Powl R, Sendeht A, Ogwuche JP, Elujoba M, Egbodo CO, Oyebode T, Daru PH, Agbaji O, Pam IC, Meloni ST, Okonkwo P, Kanki PJ. Declining rate of infection with maternal human immunodeficiency virus at delivery units in north-central Nigeria. Afr J Reprod Health. 2013 Dec; 17(4 Spec No):138-45. PMID: 24689325.
    Citations:    Fields:    Translation:HumansPHPublic Health
  29. Imade GE, Sagay AS, Chaplin B, Chebu P, Musa J, Okpokwu J, Hamel DJ, Pam IC, Agbaji O, Samuels J, Meloni S, Sankale JL, Okonkwo P, Kanki P. Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria. AIDS Res Hum Retroviruses. 2014 Feb; 30(2):127-33. PMID: 24164431.
    Citations: 11     Fields:    Translation:HumansCells
  30. Rawizza HE, Chaplin B, Meloni ST, Darin KM, Olaitan O, Scarsi KK, Onwuamah CK, Audu RA, Chebu PR, Imade GE, Okonkwo P, Kanki PJ. Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria. PLoS One. 2013; 8(9):e73582. PMID: 24069209.
    Citations: 10     Fields:    Translation:HumansCells
  31. Dinic L, Idigbe OE, Meloni S, Rawizza H, Akande P, Eisen G, Onwujekwe D, Agbaji O, Ani A, Kanki PJ. Sputum smear concentration may misidentify acid-fast bacilli as Mycobacterium tuberculosis in HIV-infected patients. . 2013 Jun 01; 63(2):168-77. PMID: 23392466.
    Citations: 2     Fields:    Translation:HumansCells
  32. Agbaji O, Thio CL, Meloni S, Graham C, Muazu M, Nimzing L, Idoko J, Sankalé JL, Ekong E, Murphy R, Kanki P, Hawkins C. Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria. . 2013 Feb 01; 62(2):204-7. PMID: 23196830.
    Citations: 1     Fields:    Translation:HumansCells
  33. Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankalé JL, Dieng-Sarr A, Agbaji O, Onwujekwe DI, Gashau W, Nkado R, Ekong E, Okonkwo P, Murphy RL, Kanki PJ. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin Infect Dis. 2011 Dec; 53(12):1283-90. PMID: 22080121.
    Citations: 57     Fields:    Translation:Humans
  34. Taiwo B, Chaplin B, Penugonda S, Meloni S, Akanmu S, Gashau W, Idoko J, Adewole I, Murphy R, Kanki P. Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1. Curr HIV Res. 2010 Apr; 8(3):194-8. PMID: 20163340.
    Citations: 7     Fields:    Translation:HumansCells
  35. Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankalé JL, Ekong E, Murphy R, Kanki P, Thio CL. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis. 2009 Oct 15; 49(8):1268-73. PMID: 19772386.
    Citations: 33     Fields:    Translation:Humans
  36. Hamel DJ, Sankalé JL, Eisen G, Meloni ST, Mullins C, Gueye-Ndiaye A, Mboup S, Kanki PJ. Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity. AIDS Res Hum Retroviruses. 2007 Oct; 23(10):1189-96. PMID: 17961103.
    Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
  37. Sankalé JL, Langevin S, Odaibo G, Meloni ST, Ojesina AI, Olaleye D, Kanki P. The complexity of circulating HIV type 1 strains in Oyo state, Nigeria. AIDS Res Hum Retroviruses. 2007 Aug; 23(8):1020-5. PMID: 17725419.
    Citations: 8     Fields:    Translation:HumansCells
  38. MacNeil A, Sarr AD, Sankalé JL, Meloni ST, Mboup S, Kanki P. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J Virol. 2007 May; 81(10):5325-30. PMID: 17329334.
    Citations: 34     Fields:    Translation:HumansCells
  39. MacNeil A, Sankale JL, Meloni ST, Sarr AD, Mboup S, Kanki P. Long-term intrapatient viral evolution during HIV-2 infection. J Infect Dis. 2007 Mar 01; 195(5):726-33. PMID: 17262716.
    Citations: 11     Fields:    Translation:HumansCells
  40. MacNeil A, Sankalé JL, Meloni ST, Sarr AD, Mboup S, Kanki P. Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo. J Virol. 2006 Aug; 80(15):7316-21. PMID: 16840312.
    Citations: 15     Fields:    Translation:HumansCells
  41. Ojesina AI, Sankalé JL, Odaibo G, Langevin S, Meloni ST, Sarr AD, Olaleye D, Kanki PJ. Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response. AIDS Res Hum Retroviruses. 2006 Aug; 22(8):770-9. PMID: 16910833.
    Citations: 11     Fields:    Translation:HumansCells
  42. Meloni ST, Sankalé JL, Hamel DJ, Eisen G, Guéye-Ndiaye A, Mboup S, Kanki PJ. Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001. J Virol. 2004 Nov; 78(22):12455-61. PMID: 15507632.
    Citations: 6     Fields:    Translation:HumansCells
  43. Meloni ST, Kim B, Sankalé JL, Hamel DJ, Tovanabutra S, Mboup S, McCutchan FE, Kanki PJ. Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3. J Virol. 2004 Nov; 78(22):12438-45. PMID: 15507630.
    Citations: 15     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Meloni's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (153)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.